Stuart Walker
Benefit-Risk Appraisal of Medicines
A systematic approach to decision-making
Ebook (PDF Format)
Benefit-risk assessment is at the centre of the approval process for every new medicine. The ability to assess the risks of a new medicine accurately and to balance these against the benefits the medicine could bring is critical for every regulatory authority and pharmaceutical company. Despite this there are very few tried and tested evaluative models currently available. The authors of this book have developed a new, pioneering tool for the assessment of benefits and risks for new medicines in development and their regulatory reviews. This model utilises a multi-criteria decision analysis which involves selecting, scoring and weighting key…
Mehr
Beschreibung
Benefit-risk assessment is at the centre of the approval process for every new medicine. The ability to assess the risks of a new medicine accurately and to balance these against the benefits the medicine could bring is critical for every regulatory authority and pharmaceutical company. Despite this there are very few tried and tested evaluative models currently available. The authors of this book have developed a new, pioneering tool for the assessment of benefits and risks for new medicines in development and their regulatory reviews. This model utilises a multi-criteria decision analysis which involves selecting, scoring and weighting key benefit and risk attributes and leads to an overall balanced appraisal benefits and risks of medicines. Benefit-Risk Appraisal of Medicines establishes the background and criteria required to assess benefit and risk in general and reviews the current practices by regulatory authorities and the pharmaceutical industry, including those models currently available. It outlines the development and evaluation of the authors' new model and analyses the implications of its implementation. Describes an innovative, systematic model which leads to transparent and responsible benefit-risk decision making Contributes important ideas to the debate on benefit-risk appraisal Provides a future framework for benefit-risk appraisal of medicines Benefit-Risk Appraisal of Medicines covers the entire process from the discovery of new medicines to their review and post marketing. This book is ideal for all those who work in the pharmaceutical industry and regulatory authorities, as well as post-graduate students of pharmaceutical medicine and clinical pharmacology.
CHF 92.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Mussen, Filip / Salek, Sam
- ISBN: 978-0-470-74812-1
- EAN: 9780470748121
- Produktnummer: 13841914
- Verlag: Wiley
- Sprache: Englisch
- Erscheinungsjahr: 2009
- Seitenangabe: 304 S.
- Plattform: PDF
- Masse: 2'710 KB
Über den Autor
Dr Sam Salek, Reader in Pharmacoepidemiology, Director - WSP Centre for Socioeconomic Research; Director - Postgraduate Course in Pharmaceutical Medicine, Cardiff University, UK. Mr Filip Mussen, Johnson & Johnson Pharmaceuticals Research and Development, Belgium. Prof Stuart Walker, President and Founder, International Institute for Regulatory Science, UK.
90 weitere Werke von Stuart Walker:
A systematic approach to decision-making
Audio Download
CHF 4.50
A systematic approach to decision-making
Audio Download
CHF 4.50
A systematic approach to decision-making
Audio Download
CHF 4.50
A systematic approach to decision-making
Ebook (EPUB Format)
CHF 5.80
A systematic approach to decision-making
Audio Download
CHF 4.50
A systematic approach to decision-making
Audio Download
CHF 5.50
A systematic approach to decision-making
Audio Download
CHF 6.50
A systematic approach to decision-making
Ebook (PDF Format)
CHF 106.00
A systematic approach to decision-making
Ebook (PDF Format)
CHF 68.00
A systematic approach to decision-making
Audio Download
CHF 4.50
A systematic approach to decision-making
Ebook (PDF Format)
CHF 94.50
Bewertungen
0 von 0 Bewertungen
Anmelden
Keine Bewertungen gefunden. Seien Sie der Erste und teilen Sie Ihre Erkenntnisse mit anderen.